Did you know that diabetes can affect your vision? Diabetic macular edema (DME) is a complication of diabetes that causes swelling in the macula, the part of your eye responsible for sharp central vision. This swelling can lead to blurry vision, trouble reading, and even vision loss.
Why This Clinical Trial Matters for Black Americans
Black Americans are disproportionately affected by DME, developing it at a higher rate compared to other races. This clinical trial, called the ELEVATUM study, is designed to investigate how a new treatment, faricimab, impacts DME in Black Americans. By enrolling in ELEVATUM, you’ll contribute valuable research that could lead to better treatments for DME in our community.
What is ELEVATUM Looking For?
ELEVATUM is seeking Black Americans who meet the following criteria:
- Age 18 or older
- Confirmed diagnosis of DME
- No prior treatment for DME in the affected eye (anti-VEGF treatment)
- Management of type 1 or type 2 diabetes
- Controlled blood sugar levels (HbA1c less than or equal to 10%)
What Happens During the Trial?
If you qualify and decide to participate, you will receive injections of faricimab directly into your eye by a doctor every 4 weeks for the first 20 weeks, then every 8 weeks for the following 32 weeks. Throughout the trial, your doctor will conduct regular checkups to monitor your vision, overall health, and response to the treatment.
Why Participate in This Clinical Trial?
There are several compelling reasons to consider participating in Elevatum:
- Advance the Treatment of DME: By participating in this clinical trial, you’ll be playing a vital role in helping researchers assess the effectiveness of faricimab for DME in Black Americans. The data collected from this trial could pave the way for the development of improved DME treatment options in the future.
- Receive Close Monitoring: Throughout the trial, you’ll benefit from close monitoring of your DME by a qualified doctor. This includes regular vision checks and assessments of your overall health.
- Potentially Experience Treatment Benefits: Faricimab may help manage your DME and potentially improve your vision.
Important Information to Consider
It’s important to understand that clinical trials involve some inherent risks. Faricimab is an investigational drug, meaning it’s still under development and its long-term effects are unknown. You may experience side effects from the medication, and some side effects can be serious. The study team will thoroughly explain all potential risks and benefits associated with the trial before you decide to participate.
How to Participate
If you have DME and are interested in learning more about ELEVATUM, talk to your doctor. They can review your medical history, determine if you meet the eligibility criteria, and help you decide if this clinical trial is the right option for you. You can also find more information about the trial online at ClinicalTrials.gov using the identifier NCT05224102.
Remember: Early detection and treatment of DME are crucial for preserving your vision. Don’t hesitate to talk to your doctor about any concerns you may have about your eyesight. Regular eye exams are essential for maintaining good eye health, especially if you have diabetes.
